Skip to main content
. 2024 Dec 5;13(23):7418. doi: 10.3390/jcm13237418

Figure 3.

Figure 3

Safety outcomes for SGLT2-i: (A) Driveline infection, (B) Diabetic ketoacidosis, (C) Acute kidney injury.